A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients

NCT00451932 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: FK778

Sponsor

Astellas Pharma Inc